Viewing Study NCT06805305


Ignite Creation Date: 2025-12-25 @ 3:31 AM
Ignite Modification Date: 2025-12-26 @ 2:13 AM
Study NCT ID: NCT06805305
Status: RECRUITING
Last Update Posted: 2025-12-22
First Post: 2025-01-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
Sponsor: Diakonos Oncology Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module